Literature DB >> 21590518

Interventional management for cancer pain.

Doris K Cope1, Zirong Zhao.   

Abstract

Cancer pain is a distressing result of disease, both primary and metastatic, as well as complications caused by cancer treatment. Medication management often is insufficient to adequately treat the ensuing pain or the complications of medical management limit acceptable dosage for pain control. In these instances, interventional modalities are an additional tool in the pain physician's armamentarium. Most commonly employed are intrathecal opioids, local anesthetic and clonidine infusions, neurolytic-nerve and sympathetic-ganglion blockade, and radiofrequency techniques. These are discussed in this article concomitantly with current outcome data as reported in the medical literature.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21590518     DOI: 10.1007/s11916-011-0206-2

Source DB:  PubMed          Journal:  Curr Pain Headache Rep        ISSN: 1534-3081


  25 in total

1.  Severe bleeding following lumbar sympathetic blockade in two patients under medication with irreversible platelet aggregation inhibitors.

Authors:  Christoph Maier; Martin Gleim; Thomas Weiss; Ulf Stachetzki; Volkmar Nicolas; Michael Zenz
Journal:  Anesthesiology       Date:  2002-09       Impact factor: 7.892

2.  Epidural hematoma after epidural steroid injection in a patient withholding enoxaparin per guidelines.

Authors:  Robert J Ain; Matthew B Vance
Journal:  Anesthesiology       Date:  2005-03       Impact factor: 7.892

3.  Three posterior percutaneous celiac plexus block techniques. A prospective, randomized study in 61 patients with pancreatic cancer pain.

Authors:  S Ischia; A Ischia; E Polati; G Finco
Journal:  Anesthesiology       Date:  1992-04       Impact factor: 7.892

4.  Epidural haematoma requiring surgical decompression following repeated cervical epidural steroid injections for chronic pain.

Authors:  K N Williams; A Jackowski; P J D Evans
Journal:  Pain       Date:  1990-08       Impact factor: 6.961

5.  Prospective randomized double-blind trial of neurolytic coeliac plexus block in patients with pancreatic cancer.

Authors:  E Polati; G Finco; L Gottin; C Bassi; P Pederzoli; S Ischia
Journal:  Br J Surg       Date:  1998-02       Impact factor: 6.939

6.  Subdural hematoma after cervical epidural steroid injection.

Authors:  Charles A Reitman; William Watters
Journal:  Spine (Phila Pa 1976)       Date:  2002-03-15       Impact factor: 3.468

7.  Pain relief by intrathecally applied morphine in man.

Authors:  J K Wang; L A Nauss; J E Thomas
Journal:  Anesthesiology       Date:  1979-02       Impact factor: 7.892

8.  Celiac plexus block versus analgesics in pancreatic cancer pain.

Authors:  Sebastiano Mercadante
Journal:  Pain       Date:  1993-02       Impact factor: 6.961

9.  Mortality associated with implantation and management of intrathecal opioid drug infusion systems to treat noncancer pain.

Authors:  Robert J Coffey; Mary L Owens; Steven K Broste; Michel Y Dubois; F Michael Ferrante; David M Schultz; Lisa J Stearns; Michael S Turner
Journal:  Anesthesiology       Date:  2009-10       Impact factor: 7.892

10.  A prospective study of EUS-guided celiac plexus neurolysis for pancreatic cancer pain.

Authors:  N T Gunaratnam; A V Sarma; I D Norton; M J Wiersema
Journal:  Gastrointest Endosc       Date:  2001-09       Impact factor: 9.427

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.